| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |